ID   741F8
AC   CVCL_N286
SY   741F8-2B9
DR   ATCC; HB-10807
DR   Wikidata; Q54604777
RX   Patent=US4938948;
RX   Patent=US5169774;
RX   PubMed=2470501;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10807.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10078.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
RX   Patent=US4938948;
RA   Ring D.B., Frankel A.E.;
RT   "Method for imaging breast tumors using labeled monoclonal anti-human
RT   breast cancer antibodies.";
RL   Patent number US4938948, 03-Jul-1990.
//
RX   Patent=US5169774;
RA   Frankel A.E., Ring D.B., Laird W.J.;
RT   "Monoclonal anti-human breast cancer antibodies.";
RL   Patent number US5169774, 08-Dec-1992.
//
RX   PubMed=2470501;
RA   Ring D.B., Kassel J.A., Hsieh-Ma S.T., Bjorn M.J., Tringale F.,
RA   Eaton A.M., Reid S.A., Frankel A.E., Nadji M.;
RT   "Distribution and physical properties of BCA200, a Mr 200,000
RT   glycoprotein selectively associated with human breast cancer.";
RL   Cancer Res. 49:3070-3080(1989).
//